Plasma prekallikrein levels are positively associated with circulating lipid levels and the metabolic syndrome in children

Applied Physiology, Nutrition and Metabolism

Volumn 35, Issue 4, 2010, Pages 518-525

  MacKenzie, James A ^a   Roosa, Kristen A ^a   Gump, Brooks B ^a   Dumas, Amy K ^a   Bendinskas, Kestutis G ^a  

^a STATE UNIVERSITY OF NEW YORK AT OSWEGO   (United States)

Author keywords

Cardiovascular disease; Children; Lipids; Metabolic syndrome; Plasma; Prekallikrein

Indexed keywords

BIOLOGICAL MARKER; CHOLESTEROL; LIPID; LIPOPROTEIN; PREKALLIKREIN; TRIACYLGLYCEROL;

AGE; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; METABOLIC SYNDROME X; PEDIGREE; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; UNITED STATES; UPREGULATION; CARDIOVASCULAR DISEASES; COMPLICATION;

AGE FACTORS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHILD; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; LIPIDS; LIPOPROTEINS; MALE; METABOLIC SYNDROME X; NEW YORK; ODDS RATIO; PEDIGREE; PREKALLIKREIN; RISK ASSESSMENT; RISK FACTORS; TRIGLYCERIDES; UP-REGULATION;

EID: 77958098009     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/H10-039     Document Type: Article

References (47)

1. Alberti, K.G., Zimmet, P., and Shaw, J. 2006. Metabolic syndrome a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23(5): 469-480. doi:10.1111/j.1464-5491.2006.01858.x. PMID: 16681555.
2. Andrew, M. 1992. Anticoagulation and thrombolysis in children. Tex. Heart Inst. J. 19(3): 168-177. PMID:15227435.
3. Berenson, G.S., Srinivasan, S.R., Bao, W., Newman, W.P.I., 3rd, Tracy, R.E., and Wattigney, W.A. 1998. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N. Engl. J. Med. 338(23): 1650-1656. doi:10.1056/NEJM199806043382302. PMID:9614255.
4. Bruda̧cǎ, I., and Cucuianu, M. 2007. Pathogenic role of abnormal fatty acids and adipokines in the portal flow. Relevance for metabolic syndrome, hepatic steatosis and steatohepatitis. Rom. J. Intern. Med. 45(2): 149-157. PMID:18333368.
5. Carvalho, A.C., Lees, R.S., Vaillancourt, R.A., Cabral, R.B., and Colman, R.W. 1978. Activation of the kallikrein system in hyperbetalipoproteinemia. J. Lab. Clin. Med. 91(1): 117-122. PMID:201701.
6. CDC. 2007. A SAS program for the CDC growth charts. Available from http://www.cdc.gov/NCCDPHP/dnpa/growthcharts/resources/sas.htm. [Accessed May 2009.]
7. CDC-NHANES. 1996. NHANES III Anthropometric Procedures Video. Public Health Services, Washington, D.C.
8. Centers for Disease Control and Prevention. 2004. The burden of chronic diseases and their risk factors: National and state perspectives 2004. US Department of Health and Human Services, Atlanta.
9. Christe, M., Gattlen, P., Fritschi, J., Lammle, B., Berger, W., Marbet, G.A., and Duckert, F. 1984. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy. Thromb. Haemost. 52(3): 221-223. PMID:6085193.
10. Cook, S., Weitzman, M., Auinger, P., Nguyen, M., and Dietz, W.H. 2003. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch. Pediatr. Adolesc. Med. 157(8): 821-827. doi:10.1001/archpedi.157.8.821. PMID: 12912790.
11. Daniels, S.R., Jacobson, M.S., McCrindle, B.W., Eckel, R.H., and Sanner, B.M. 2009. American Heart Association Childhood Obesity Research Summit: executive summary. Circulation, 119(15): 2114-2123. doi:10.1161/CIRCULATIONAHA.109. 192215. PMID:19332459.
12. de Ferranti, S.D., Gauvreau, K., Ludwig, D.S., Neufeld, E.J., Newburger, J.W., and Rifai, N. 2004. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation, 110(16): 2494-2497. doi:10.1161/01.CIR.0000145117. 40114.C7. PMID:15477412.
13. De La Cadena, R.A., Scott, C.F., and Colman, R.W. 1987. Evaluation of a microassay for human plasma prekallikrein. J. Lab. Clin. Med. 109(5): 601-607. PMID:3646287.
14. Falkner, B., Gidding, S.S., Portman, R., and Rosner, B. 2008. Blood pressure variability and classification of prehypertension and hypertension in adolescence. Pediatrics, 122(2): 238-242. doi:10.1542/peds.2007-2776. PMID:18676538.
15. Fernández, J.R., Redden, D.T., Pietrobelli, A., and Allison, D.B. 2004. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J. Pediatr. 145(4): 439-444. doi:10.1016/j.jpeds.2004.06.044. PMID:15480363.
16. Ford, E.S. 2004. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis, 173(2): 309-314. doi:10.1016/j.atherosclerosis. 2003.12.022. PMID:15064107.
17. Ford, E.S., and Li, C. 2008. Defining the metabolic syndrome in children and adolescents: will the real definition please stand up? J. Pediatr. 152(2): 160-164, e13. doi:10.1016/j.jpeds.2007. 07.056. PMID:18206681.
18. Jaffa, A.A., Durazo-Arvizu, R., Zheng, D., Lackland, D.T., Srikanth, S., Garvey, W.T., and Schmaier, A.H.; DCCT/EDIC Study Group. 2003. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes, 52(5): 1215-1221. doi:10.2337/diabetes.52.5.1215. PMID:12716755.
19. Johnson, W.D., Kroon, J.J., Greenway, F.L., Bouchard, C., Ryan, D., and Katzmarzyk, P.T. 2009. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch. Pediatr. Adolesc. Med. 163(4): 371-377. doi:10.1001/archpediatrics. 2009.3. PMID:19349567.
20. Kallen, R.J., and Lee, S.K. 1975. A study of the plasma kinin-genrating system in children with the minimal lesion, idiopathic nephrotic syndrome. Pediatr. Res. 9(9): 705-709. doi:10.1203/ 00006450-197509000-00004. PMID:53808.
21. Kedzierska, K., Ciechanowski, K., Gołembiewska, E., Safranow, K., Ciechanowicz, A., Domański, L., et al. 2005. Plasma prekallikrein as a risk factor for diabetic retinopathy. Arch. Med. Res. 36(5): 539-543. doi:10.1016/j.arcmed.2005.03.050. PMID: 16099335.
22. Kluft, C. 1978. Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. J. Lab. Clin. Med. 91(1): 83-95. PMID:618993.
23. Larsen, L.F., Marckmann, P., Bladbjerg, E.M., Ostergaard, P.B., Sidelmann, J., and Jespersen, J., Larsen, L.F., et al. 2000. The link between high-fat meals and postprandial activation of blood coagulation factor VII possibly involves kallikrein. Scand. J. Clin. Lab. Invest. 60(1): 45-54. doi:10.1080/00365510050185038. PMID:10757453.
24. Le, N.A., and Walter, M.F. 2007. The role of hypertriglyceridemia in atherosclerosis. Curr. Atheroscler. Rep. 9(2): 110-115. doi: 10.1007/s11883-007-0006-7. PMID:17877919.
25. Li, S., Chen, W., Srinivasan, S.R., Bond, M.G., Tang, R., Urbina, E.M., and Berenson, G.S. 2003. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA, 290(17): 2271-2276. doi:10.1001/jama.290.17.2271. PMID:14600185.
26. Lin, J.H., Shiigai, T., and Takeuchi, J. 1984. Relation of family history of hypertension to platelet aggregation, ratio of total cholesterol to HDL cholesterol and urinary kallikrein excretion. Bull. Tokyo Med. Dent. Univ. 31(1): 13-19. PMID:6430581.
27. Mahoney, L.T., Burns, T.L., Stanford, W., Thompson, B.H., Witt, J.D., Rost, C.A., and Lauer, R.M. 1996. Coronary risk factors measured in childhood and young adult life are associated with coronary artery calcification in young adults: the Muscatine Study. J. Am. Coll. Cardiol. 27(2): 277-284. doi:10.1016/0735-1097(95)00461-0. PMID:8557894.
28. Mallela, J., Yang, J., and Shariat-Madar, Z. 2009. Prolylcarboxypeptidase: a cardioprotective enzyme. Int. J. Biochem. Cell Biol. 41(3): 477-481. doi:10.1016/j.biocel.2008.02.022. PMID: 18396440.
29. McCullough, P.A. 2005. Effect of lipid modification on progression of coronary calcification. J. Am. Soc. Nephrol. 16(11 Suppl. 2): S115-S119. doi:10.1681/ASN.2005060664. PMID:16251246.
30. McGill, H.C., Jr., McMahan, C.A., Herderick, E.E., Malcom, G.T., Tracy, R.E., and Strong, J.P. 2000. Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr. 72(Suppl. 5): 1307S-1315S. PMID:11063473.
31. Merlo, C., Wuillemin, W.A., Redondo, M., Furlan, M., Sulzer, I., Kremer-Hovinga, J., et al. 2002. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis, 161(2): 261-267. doi:10.1016/S0021-9150(01)00666-9. PMID:11888508.
32. Montanari, D., Yin, H., Dobrzynski, E., Agata, J., Yoshida, H., Chao, J., and Chao, L. 2005. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes, 54(5): 1573-1580. doi:10.2337/diabetes.54.5.1573. PMID:15855348.
33. Morrison, J.A., Friedman, L.A., Wang, P., and Glueck, C.J. 2008. Metabolic syndrome in childhood predicts adult metabolic syn drome and type 2 diabetes mellitus 25 to 30 years later. J. Pediatr. 152(2): 201-206. doi:10.1016/j.jpeds.2007.09.010. PMID:18206689.
34. NCEP Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106(25): 3143-3421. PMID: 12485966.
35. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. 2004. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114(Suppl. 2, 4th Report): 555-576. doi:10.1542/peds.114.2.S2. 555. PMID:15286277.
36. Ogden, C.L., Carroll, M.D., and Flegal, K.M. 2008. High body mass index for age among US children and adolescents, 2003-2006. JAMA, 299(20): 2401-2405. doi:10.1001/jama.299.20. 2401. PMID:18505949.
37. Orakzai, S.H., Nasir, K., Blaha, M., Blumenthal, R.S., and Raggi, P. 2009. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis, 202(1): 289-295. doi:10.1016/j.atherosclerosis.2008. 03.014. PMID:18452924.
38. Raitakari, O.T., Juonala, M., Kähonen, M., Taittonen, L., Laitinen, T., Mäki-Torkko, N., et al. 2003. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA, 290(17): 2277-2283. doi:10.1001/jama.290.17.2277. PMID:14600186.
39. Ryo, M., Nakamura, T., Kihara, S., Kumada, M., Shibazaki, S., Takahashi, M., et al. 2004. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 68(11): 975-981. doi:10.1253/circj.68.975. PMID:15502375.
40. Sainz, I.M., Pixley, R.A., and Colman, R.W. 2007. Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology. Thromb. Haemost. 98(1): 77-83. PMID:17597995.
41. Saito, I., Iso, H., Kokubo, Y., Inoue, M., and Tsugane, S. 2009. Metabolic syndrome and all-cause and cardiovascular disease mortality: Japan Public Health Center-based Prospective (JPHC) Study. Circ. J. 73(5): 878-884. doi:10.1253/circj.CJ-08-1025. PMID:19282609.
42. Schmaier, A.H. 2008. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int. Immunopharmacol. 8(2): 161-165. doi:10.1016/j.intimp.2007.08.022. PMID: 18182220.
43. Sharma, J.N., and Kesavarao, U. 2007. Changes in plasma prekal-likrein activity, blood pressure, and left ventricular thickness in hypertensive and normotensive diabetic rats. Methods Find. Exp. Clin. Pharmacol. 29(2): 75-78. doi:10.1358/mf.2007.29.2. 1063494. PMID:17440623.
44. Thomas, S.H., Winsor, G.R., Pang, P.S., Driscoll, K.A., and Parry, B.A. 2004. Use of a radial artery compression device for noninvasive, near-continuous blood pressure monitoring in the ED. Am. J. Emerg. Med. 22(6): 474-478. doi:10.1016/j.ajem.2004. 07.027. PMID:15520942.
45. Torstila, I., Kaukola, S., Manninen, V., Virtamo, J., and Mälkonen, M. 1982. Plasma prekallikrein, kallikrein inhibitors, kininogen and lipids during gemfibrozil treatment in type II dyslipidaemia. Acta Med. Scand. Suppl. 668: 123-129. PMID:6188330.
46. Williams, R.R., Hunt, S.C., Hasstedt, S.J., Hopkins, P.N., Wu, L.L., Berry, T.D., et al. 1990. Genetics of hypertension: what we know and don't know. Clin. Exp. Hypertens. A, 12(5): 865-876. doi:10.3109/10641969009073505. PMID:2208756.
47. Zinner, S.H., Margolius, H.S., Rosner, B., Keiser, H.R., and Kass, E.H. 1976. Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes. Am. J. Epidemiol. 104(2): 124-132. PMID:952282.